Aminoglycoside-modifying Enzymes in Carbapenem-resistant Pseudomonas aeruginosa Clinical Isolates


Creative Commons License

Tanrıverdi Çaycı Y., Cirit O. S., Bıyık İ., Cinar C., Gür Vural D., BİLGİN K., ...Daha Fazla

MEDITERRANEAN JOURNAL OF INFECTION MICROBES AND ANTIMICROBIALS, cilt.11, 2022 (ESCI) identifier

Özet

Introduction: Aminoglycosides are the drug of choice for the treatment of Pseudomonas aeruginosa infections. Aminoglycoside resistance in P. aeruginosa often occurred via acquired aminoglycoside-modifying enzymes (AMEs). In this study, we aimed to investigate the presence of AME in P. aeruginosa in carbapenem-resistant and carbapenem-susceptible isolates.